Saudi Arabia Approves Conducting International Refereed Clinical Trial for Coronavirus Medication

Saudi Arabia Approves Conducting International Refereed Clinical Trial for Coronavirus Medication

The Saudi Food and Drug Authority (SFDA) approved conducting international refereed clinical trial for Coronavirus (COVID-19) medication in five hospitals in the Kingdom of Saudi Arabia under the title: (An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care).

The clinical trial aims to obtain reliable data related to the effectiveness and safety of a number of used antivirals that may contribute to the medication of the Coronavirus (COVID-19). These antivirals are: Remdesivir, Chloroquine, Lopinavir with Ritonavir and Interferon ?1b.

The clinical trial is being conducted under the joint auspices of the World Health Organization (WHO) and a number of health entities in the Kingdom, under the supervision of SFDA.